Objective: To compare the clinical, radiographic, and histological healing patterns between the immediate and delayed applications of bone morphogenetic protein-2 (BMP-2) in damaged extraction sockets in dogs. Materials and methods: The distal roots of the fourth premolars of the mandible were extracted bilaterally in five beagle dogs, and buccal bone defects (4 mm wide and 9 mm high) were surgically created. Collagenated biphasic calcium phosphate (CBCP) soaked for 10 min in 100 μL of BMP-2 solution was applied immediately to the defect site in the control group. In the test group, the BMP-2 solution of same dose was injected into the grafted site 2 weeks after grafting with a saline-soaked CBCP. The dogs were sacrificed 2 weeks later. Cl...
OBJECTIVES: The objective of this study was to determine the effect of bone morphogenetic protein-2 ...
Objectives: The objective of this study was to evaluate new bone formation derived from freshly crus...
BACKGROUND: Conflicting data exist on the outcome of placing Bio-Oss® (Geitslich Pharm AG, Wolhausen...
Objective: To compare the clinical, radiographic, and histological healing patterns between the imme...
Objective: To compare the clinical, radiographic, and histological healing patterns between the imme...
Purpose: To compare the efficiency of recombinant human bone morphogenetic protein 2 (rhBMP2)/absorb...
OBJECTIVES: The objective of this study was to elucidate the socket healing process and biodegradati...
OBJECTIVES: This study evaluated the dimensional ridge alteration in a buccal-bone-deficient extract...
Objectives: The evaluation of three different drug delivery modes of bone morphogenetic protein-2 (B...
OBJECTIVES: The aims of the present study were (i) to determine the short-term effects of putty-type...
OBJECTIVES: The objective of this experiment was to test whether or not a synthetic bone substitute ...
OBJECTIVE: To assess the healing outcomes at buccal dehiscence defects after 4 months following impl...
OBJECTIVES The purpose of this study was to compare the effects of rhBMP2 with rhBMP9 on ridge au...
OBJECTIVES The objective of this experiment was to test whether or not a synthetic bone substitute ...
Aim: To compare the influence of autologous or deproteinized bovine bone mineral as grafting materia...
OBJECTIVES: The objective of this study was to determine the effect of bone morphogenetic protein-2 ...
Objectives: The objective of this study was to evaluate new bone formation derived from freshly crus...
BACKGROUND: Conflicting data exist on the outcome of placing Bio-Oss® (Geitslich Pharm AG, Wolhausen...
Objective: To compare the clinical, radiographic, and histological healing patterns between the imme...
Objective: To compare the clinical, radiographic, and histological healing patterns between the imme...
Purpose: To compare the efficiency of recombinant human bone morphogenetic protein 2 (rhBMP2)/absorb...
OBJECTIVES: The objective of this study was to elucidate the socket healing process and biodegradati...
OBJECTIVES: This study evaluated the dimensional ridge alteration in a buccal-bone-deficient extract...
Objectives: The evaluation of three different drug delivery modes of bone morphogenetic protein-2 (B...
OBJECTIVES: The aims of the present study were (i) to determine the short-term effects of putty-type...
OBJECTIVES: The objective of this experiment was to test whether or not a synthetic bone substitute ...
OBJECTIVE: To assess the healing outcomes at buccal dehiscence defects after 4 months following impl...
OBJECTIVES The purpose of this study was to compare the effects of rhBMP2 with rhBMP9 on ridge au...
OBJECTIVES The objective of this experiment was to test whether or not a synthetic bone substitute ...
Aim: To compare the influence of autologous or deproteinized bovine bone mineral as grafting materia...
OBJECTIVES: The objective of this study was to determine the effect of bone morphogenetic protein-2 ...
Objectives: The objective of this study was to evaluate new bone formation derived from freshly crus...
BACKGROUND: Conflicting data exist on the outcome of placing Bio-Oss® (Geitslich Pharm AG, Wolhausen...